Voltus to Deliver $240 Million to Customers in Record 2025, Dispatched Every Day to Support Grid Reliability and Affordability

Voltus to Deliver $240 Million to Customers in Record 2025, Dispatched Every Day to Support Grid Reliability and Affordability Leading load flexibility platform manages 8.1 gigawatts while delivering 816,000 megawatt-hours of relief, proving flexible load is now essential grid infrastructure; announces Customer Peak Performance Award recipients GlobeNewswire December 16, 2025 SAN FRANCISCO, Dec. 16, 2025 […]

Milwaukee Tool expands operations into Georgina with new Service Hub at Keswick Business Park

Milwaukee Tool expands operations into Georgina with new Service Hub at Keswick Business Park Major investment signals growing momentum in Georgina's industrial and employment sector GlobeNewswire December 16, 2025 Georgina, ON, Dec. 16, 2025 (GLOBE NEWSWIRE) — The Town of Georgina is pleased to welcome Milwaukee Tool, a global leader in professional cordless power tools,

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics Reports Inducement Grants GlobeNewswire December 16, 2025 BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on December 15, 2025, Elicio granted an aggregate of 157,193 inducement stock

Fyxt Enters Q4 with Record Growth, Managing Over 800 Million Square Feet Through AI-Driven Property Operations

Fyxt Enters Q4 with Record Growth, Managing Over 800 Million Square Feet Through AI-Driven Property Operations GlobeNewswire December 16, 2025 VENICE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — Fyxt, the AI-first property operations platform for commercial real estate, announced record growth entering Q4, tripling its customer footprint and expanding its managed portfolio to more than

DIRTT Reports Continued Year-End Commercial Momentum and Project Wins

DIRTT Reports Continued Year-End Commercial Momentum and Project Wins GlobeNewswire December 16, 2025 CALGARY, Alberta, Dec. 16, 2025 (GLOBE NEWSWIRE) — DIRTT (“DIRTT”, the “Company”, “we”, “our”, “us” or “ours”) (TSX: DRT; OTCQX: DRTTF), a leader in industrialized construction, today reported steady late-year commercial activity supported by accelerating customer decision-making and consistent project volume. November

Axalta Releases 2025 Global Automotive Color Popularity Report

Axalta Releases 2025 Global Automotive Color Popularity Report Industry's longest running and most comprehensive color account shows neutrals continuing to anchor the global palette GlobeNewswire December 16, 2025 PHILADELPHIA, Dec. 16, 2025 (GLOBE NEWSWIRE) — Axalta (NYSE: AXTA), a leading global coatings company, today released its 73rd annual Global Automotive Color Popularity Report. The report

CUSIP Request Volumes for New Corporate Securities Rise in November

CUSIP Request Volumes for New Corporate Securities Rise in November Municipal Issuance Slows GlobeNewswire December 16, 2025 NORWALK, Conn., Dec. 16, 2025 (GLOBE NEWSWIRE) — CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for November 2025. The report, which tracks the issuance of new security identifiers as an early

BBSI Introduces New Regional VP for Northern California

BBSI Introduces New Regional VP for Northern California GlobeNewswire December 16, 2025 VANCOUVER, Wash., Dec. 16, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., today announced the promotion of Larry Lewis to Regional

Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)

Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) LANDSCAPE open-label trial to evaluate safety of laru-zova administered bilaterally GlobeNewswire December 16, 2025 LONDON and CAMBRIDGE, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Beacon Therapeutics Holdings Limited ('Beacon Therapeutics' or 'the Company'), a leading clinical-stage biotechnology company

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic GlobeNewswire December 16, 2025 REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models of asthma, acute lung inflammation and dermatitis Efficacy

Scroll to Top